Rapid characterization of structural and functional similarity for a candidate bevacizumab (Avastin) biosimilar using a multipronged mass‐spectrometry‐based approach-Reference-Cited by-同舟云学术

Rapid characterization of structural and functional similarity for a candidate bevacizumab (Avastin) biosimilar using a multipronged mass‐spectrometry‐based approach

Published:2019-05-23 Issue:8 Volume:11 Page:1207-1217
ISSN:1942-7603
Container-title:Drug Testing and Analysis
language:en
Short-container-title:Drug Test Anal

Author:

Brown Kerene A.¹²,Rajendran Shanthi³,Dowd Jason³,Wilson Derek J.¹²^ORCID

Affiliation:

1. Chemistry DepartmentYork University Toronto ON Canada

2. The Centre for Research in Mass SpectrometryYork University Toronto ON Canada

3. Apobiologix (division of Apotex Inc.) Toronto ON Canada

Funder

Natural Sciences and Engineering Research Council of Canada

Publisher

Wiley

Subject

Spectroscopy,Pharmaceutical Science,Environmental Chemistry,Analytical Chemistry

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/dta.2609

Reference72 articles.

1. Therapeutic Recombinant Monoclonal Antibodies

2. Therapeutic antibodies: successes, limitations and hopes for the future

3. Worldwide experience with biosimilar development

4. Analytical tools for characterizing biopharmaceuticals and the implications for biosimilars

5. Different culture methods lead to differences in glycosylation of a murine IgG monoclonal antibody

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Recent advances in structural mass spectrometry methods in the context of biosimilarity assessment: from sequence heterogeneities to higher order structures;Journal of Pharmaceutical and Biomedical Analysis;2023-11

2. Assessment of structural and functional similarity of biosimilar products: Bevacizumab as a case study;Journal of Chromatography B;2023-09

3. Comparative stability study and aggregate analysis of Bevacizumab marketed formulations using advanced analytical techniques;Heliyon;2023-09

4. Bioprocess Challenges in Purification of Therapeutic Protein Charge Variants;Biotechnology and Bioprocess Engineering;2023-05-29

5. NIR photothermal-activable drug-conjugated microcapsules for in vitro targeted delivery and release: An alternative treatment of diabetic retinopathy;International Journal of Pharmaceutics;2023-03